Regulatory Press Releases

Stille AB (publ) (“Stille”) has entered into an agreement to acquire all shares outstanding in Surgical Holdings (“Surgical Holdings”) for a consideration of approximately GBP 7.7 million (corresponding to SEK 100 million) on a cash and debt-free basis. Through the acquisition, Stille continues its strategic expansion, further strengthening its geographic reach, product- and...

Torshälla, Sweden – 9 May 2025 – The Board of Directors of Stille AB (“Stille”), a leading provider of premium surgical instruments and advanced surgical tables for high-precision procedures, is pleased to announce the appointment of Ulrik Berthelsen as its new Chief Executive Officer, effective 12 May 2025. With a distinguished background in the medical technology sector...

The 2025 annual general meeting in Stille AB was held on Wednesday, May 7, 2025, on Norrlandsgatan 11 in Stockholm. The main resolutions passed at the annual general meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the annual general meeting and the complete proposals, which are available on the company’s website...

Stille AB (publ) informs that Niklas Carlén has decided to step down from his position as Chief Financial Officer (CFO) of Stille to pursue a new opportunity outside the company. "I would like to thank Niklas for his significant contributions over the past five years and wish him all the best in his future endeavors. He has played an important role in many key initiatives at Stille, including...

Stille AB (publ) today presents the report for the first quarter 2025. Revenue amounted to 129.3 MSEK (139.7) impacted by temporary delivery restrictions and the phase-out of non-strategic products.“Stille starts 2025 with a quarter marked by temporary challenges.” says Torbjörn Sköld but also points out,“Order intakeremained strong, in line with financial targets, providing...